Podcast Episodes
Back to Search
Episode 118: Prostate cancer highlights at EAU
Season 1 Episode 118
Peter Albers discusses three timely prostate cancer topics from the recent EAU meeting.
5 years, 3 months ago
Episode 117: PD1/VEGF adverse event management in renal cancer
Season 1 Episode 117
Betsy Plimack discusses the tricks of the trade.
5 years, 3 months ago
Episode 116: Renal cancer surgery controversies at EAU
Season 1 Episode 116
Grant Stewart gives his opinion on timely RCC surgical topics surrounding the European Association of Urology meeting
5 years, 3 months ago
Episode 112: Genomic classifier of high risk African American men with prostate cancer identifying a high-risk population
Season 1 Episode 112
Kosj Yamoah (Moffitt Cancer Center) describes the work he presented at ASCO 2021.
5 years, 3 months ago
Episode 115: Triplet therapy for 1st line metastatic prostate cancer
Season 1 Episode 115
Eric Small is quizzed about this topic. Tom gets confused between York and Leeds.
5 years, 3 months ago
Episode 114: Radionucleotides in prostate cancer
Season 1 Episode 113
Chris Sweeney and Silke Gillessen give their opinion of recent data.
5 years, 4 months ago
Episode 113: ASCO 2021 Enazlutamide +/- Radium-223
Season 1 Episode 112
Silke Gillessen gives a safety update from this EORTC study focusing on fractures.
5 years, 4 months ago
Episode 112: Genomic classifier of high risk African American men with prostate cancer identifying a high-risk population
Season 1 Episode 112
Kosj Yamoah (Moffitt Cancer Center) describes the work he presented at ASCO 2021.
5 years, 4 months ago
Episode 111: The randomised phase 3 CANTATA in metastatic renal cancer
Season 1 Episode 111
Nizar Tannir describes the results of this trial with a novel glutaminase inhibitor.
5 years, 4 months ago
Episode 110: PEACE1 - Triplet therapy in prostate cancer
Season 1 Episode 110
Karim Fizazi describes the results of this randomised, potentially practice-changing trial.
5 years, 4 months ago